Akira Nagahara
Papers
2
Total Citations
20
H-Index
1
About
Akira Nagahara is a urologic surgeon and researcher whose work focuses on optimizing surgical outcomes for patients with renal cell carcinoma (RCC) and bladder cancer. His most cited study, a 2021 comparison of robot-assisted partial nephrectomy (RAPN) versus percutaneous cryoablation (PCA) for T1 RCC, has garnered 19 citations and provides critical insights into nephron-sparing approaches, evaluating both oncological control and renal function preservation. This work directly informs clinical decision-making for early-stage kidney cancer. More recently, Nagahara has investigated perioperative risk factors in bladder cancer, identifying preoperative C-reactive protein (CRP) as a predictive marker for prolonged hospital stay after radical cystectomy—a finding with practical implications for patient counseling and resource allocation. His research methodology, combining retrospective analysis with clinically relevant endpoints, demonstrates a commitment to evidence-based improvements in surgical care. By addressing both technical comparisons and preoperative risk stratification, Nagahara’s contributions help refine treatment algorithms and postoperative management, ultimately aiming to enhance recovery and long-term outcomes for patients undergoing major urologic oncology procedures.
Research Focus
Key Achievements
Top Papers
- 1
- 2